DBC2 is essential for transporting vesicular stomatitis virus glycoprotein

Area of Science:

• Molecular Biology
• Cell Biology
• Cancer Research

Background:

• Deleted in breast cancer 2 (DBC2) is a tumor suppressor gene implicated in breast and lung cancers.
• DBC2, a member of the RHO GTPase family, possesses a unique C-terminal Broad-Complex/Tramtrack/Bric a Brac (BTB) domain.
• Prior research suggests DBC2's involvement in ubiquitination, cell-cycle control, cytoskeleton organization, and protein transport.

Purpose of the Study:

• To investigate the specific role of DBC2 in the cellular protein transport pathway.
• To elucidate the mechanism by which DBC2 influences protein trafficking within the cell.

Main Methods:

• Utilized a vesicular stomatitis virus glycoprotein (VSVG) fused with green fluorescent protein as a model cargo.
• Employed knockdown of DBC2 in 293 cells to assess its impact on VSVG transport.
• Investigated the dependence of DBC2 mobility on an intact microtubule network.

Main Results:

• DBC2 knockdown significantly impaired the vesicular stomatitis virus glycoprotein (VSVG) transport system in 293 cells.
• The mobility of DBC2 was found to be dependent on a functional microtubule network.
• These findings indicate a direct role for DBC2 in microtubule-mediated protein transport.

Conclusions:

• DBC2 plays a critical role in the microtubule-dependent transport of VSVG.
• The study establishes DBC2's essential function in facilitating protein movement from the endoplasmic reticulum to the Golgi apparatus.